World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
23812
World Ranking
17992
National Ranking
8968

Overview

Mark S. Talamonti is affiliated with NorthShore University HealthSystem in the United States. Their research spans medicine with a focus on immunology and microbiology, encompassing 177 and 45 publications in these primary fields, respectively.

Their subfields of study include dermatology, immunology, surgery, physiology, and immunology and allergy. Dermatology and skin diseases represent a central topic, supported by 88 publications. Additional research interests cover psoriasis treatment and pathogenesis, asthma and respiratory diseases, allergic rhinitis and sensitization, pancreatic and hepatic oncology research, surgical simulation and training, and autoimmune bullous skin diseases.

Mark S. Talamonti has published in multiple scientific venues, frequently contributing to:

  • Expert Opinion on Biological Therapy
  • Journal of Clinical Medicine
  • HPB
  • Journal of the European Academy of Dermatology and Venereology
  • Dermatology and Therapy

Recent notable papers include:

  • "Virtual Surgical Fellowship Recruitment During COVID-19 and Its Implications for Resident/Fellow Recruitment in the Future," 2020, Annals of Surgical Oncology
  • "Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy," 2023, JAMA
  • "Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study," 2020, Journal of the European Academy of Dermatology and Venereology
  • "Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature," 2020, Expert Opinion on Biological Therapy
  • "Quality of Life and Psychological Impact in Patients with Atopic Dermatitis," 2021, Journal of Clinical Medicine

Their collaborative work involves frequent coauthors such as:

  • Marco Galluzzo
  • Luca Bianchi
  • Claudia Paganini
  • Melissa E. Hogg
  • Concetta Potenza

Best Publications

  • Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

    Richard A. Moffitt;Raoud Marayati;Elizabeth L. Flate;Keith E. Volmar

  • Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement.

    Mark P. Callery;Kenneth J. Chang;Elliot K. Fishman;Mark S. Talamonti

  • Extent of surgery affects survival for papillary thyroid cancer.

    Karl Y. Bilimoria;David J. Bentrem;Clifford Y. Ko;Clifford Y. Ko;Andrew K. Stewart

  • Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years.

    Karl Y Bilimoria;David Jason Bentrem;Jeffrey D Wayne;Clifford Y. Ko;Clifford Y. Ko

  • Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer

    Mark S. Talamonti;Mark S. Roh;Steven A. Curley;Gary E. Gallick

  • National Failure to Operate on Early Stage Pancreatic Cancer

    Karl Y. Bilimoria;David J. Bentrem;Clifford Y. Ko;Clifford Y. Ko;Andrew K. Stewart

  • Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.

    Karl Y Bilimoria;Karl Y Bilimoria;David Jason Bentrem;Clifford Y. Ko;Clifford Y. Ko;Jamie Ritchey

  • Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.

    Matthew H.G. Katz;Qian Shi;Syed A. Ahmad;Joseph M. Herman

  • Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches.

    David A. Kooby;David A. Kooby;Theresa Gillespie;Theresa Gillespie;David Jason Bentrem;Attila Nakeeb

  • Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer

    Ryan P. Merkow;Karl Y. Bilimoria;James S. Tomlinson;Jennifer L. Paruch;Jennifer L. Paruch

  • Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients.

    Karl Y. Bilimoria;Mark S. Talamonti;James S. Tomlinson;Andrew K. Stewart

  • Wait times for cancer surgery in the United States: Trends and predictors of delays

    Karl Y Bilimoria;Clifford Y. Ko;Clifford Y. Ko;James S. Tomlinson;Andrew K. Stewart

  • Learning sentinel node biopsy: results of a prospective randomized trial of two techniques.

    Monica Morrow;Alfred W. Rademaker;Kevin P. Bethke;Mark S. Talamonti

  • Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management.

    Mark S. Talamonti;Laura H. Goetz;Sambasiva Rao;Raymond J. Joehl

  • A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma

    Mark S. Talamonti;William Small;Mary F. Mulcahy;Jeffrey D. Wayne

  • Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.

    Karl Y. Bilimoria;Karl Y. Bilimoria;David J. Bentrem;Clifford Y. Ko;Clifford Y. Ko;James S. Tomlinson

  • Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors.

    Katherine A. Yao;Mark S. Talamonti;Albert Nemcek;Peter Angelos

  • A multi-institutional comparison of perioperative outcomes of robotic and open pancreaticoduodenectomy

    Amer H. Zureikat;Lauren M. Postlewait;Yuan Liu;Theresa W. Gillespie

  • A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.

    Jeran K. Stratford;David J. Bentrem;Judy M. Anderson;Cheng Fan

  • Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.

    Kent T. Sato;Robert J. Lewandowski;Mary F. Mulcahy;Bassel Atassi

Frequent Co-Authors

David J. Bentrem
David J. Bentrem Northwestern University
Karl Y. Bilimoria
Karl Y. Bilimoria Indiana University
Clifford Y. Ko
Clifford Y. Ko University of California, Los Angeles
Thomas E. Adrian
Thomas E. Adrian Northwestern University
David P. Winchester
David P. Winchester American College of Surgeons
Mary F. Mulcahy
Mary F. Mulcahy Northwestern University
Al B. Benson
Al B. Benson Northwestern University
Henry N. Wagner
Henry N. Wagner Penn State Cancer Institute
Alfred W. Rademaker
Alfred W. Rademaker Northwestern University
David A. Kooby
David A. Kooby Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but want alternative education routes or careers, there are several online pathways to consider. For nurses aiming to advance quickly, the shortest DNP program provides a direct, efficient route to a Doctor of Nursing Practice, opening new clinical and leadership roles.

Some students prefer to enter the healthcare field as soon as possible. A fast track medical program, such as accelerated Licensed Practical Nurse (LPN) courses, offers a quick start for those who want hands-on patient care experience without the long commitment of medical school.

Mental health careers are also in high demand. The fast track mental health nursing programs allow registered nurses to specialize as psychiatric mental health nurse practitioners in less time, addressing urgent needs in mental healthcare.

Not all medical careers require direct patient care. If you’re interested in health policy, business, or management, the cheapest online healthcare administration degree can provide a flexible and affordable way to move into leadership and administrative roles in hospitals and related organizations.

Best Scientists Citing Mark S. Talamonti

Trending Scientists